Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE. - ALR TECHNOLOGIES INC. | exh99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 17, 2011 (October 17, 2011)
ALR TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
NEVADA
(State or other jurisdiction of incorporation)
000-30414
(Commission File No.)
3350 Riverwood Pkwy
Suite 1900
Atlanta, Georgia 30339
(Address of principal executive offices) (Zip Code)
(678) 881-0002
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 7.01 REGULATION FD DISCLOSURE.
On October 17, 2011, we announced that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for our Health-e-Connect (HeC) System for remote monitoring of patients in support of effective diabetes management problems.
ITEM 9.01 EXHIBITS AND FINANCIAL STATEMENTS.
|
Exhibit
|
Document Description
|
|
99.1
|
Press Release.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated this 17th day of October, 2011.
|
ALR TECHNOLOGIES INC.
|
||
|
BY:
|
LAWRENCE WEINSTEIN
|
|
|
Lawrence Weinstein
|
||
|
President, Chief Operating Officer and a member of the Board of Directors
|
||
-2-